|
| Search for Cases |
|
Case Details |
|
Case Code: FINC137
|
| Case Length: 7 Pages |
| Period: 2008 - 2017 |
| Pub Date: 2018 |
| Teaching Note: Available |
| Price:Rs.200 |
| Organization : Lupin Limited |
Industry : Pharmaceuticals
|
| Countries : India |
| Themes: Risk Return Analysis in Corporate Finance |
|
|
|
|
Lupin Stock: Risk and Return |
|
|
|
|
|
|
| <<Previous Page |
|
EXCERPTS |
|
|
| |
The Indian pharmaceutical sector accounted for about 3.1–3.6 % of the global pharmaceutical industry in value terms and 10 % in volume terms and was expected to grow at a Compound Annual Growth Rate (CAGR) of 15.92 % to US$ 55 billion by 2020 from US$ 20 billion in 2015. Indian drugs were exported to more than 200 countries in the world, with the US being the key market.. |
| |
 |
| or |
 |
| or |
PayPal (5 USD)
|
|
|
| |
| USFDA WARNING LETTER |
| On November 6, 2017, the USFDA issued a WL for Lupin’s formulations manufacturing facilities at Goa and Indore (Pithampur Unit II). The next day, Tuesday, November 7, 2017, after the news broke in the market, Lupin’s share price fell to a 52-week low of Rs.846.20. Together, these two plants contributed more than half of the drug maker’s US sales and approximately 20 per cent of its total sales. The firm had earlier received three form 483 observations in Goa on April 7, 2017, and six form 483 observations in Pithampur (Unit II) on May 19, 2017, and responded to them. |
| |
| EXHIBITS |
Exhibit 1: Daily Stock Price of Lupin Ltd and NIFTY 50 for the month, November, 2017
Graph 1 : Lupin Daily Stock Prices in November 2017
Exhibit 2: Monthly Stock Price of Lupin Ltd and NIFTY 50 (Nov 2016 to Nov 2017)
Exhibit 3: Yearly data Lupin Stock and NIFTY 50 (Nov 2008- Nov 2017)
Exhibit 4: Lupin Stock Dividend History (2008- 2017)
|
|
|
|
